According to a recent market survey conducted by Future Market Insights (FMI), the global Small Molecule-Drug Conjugates Market will be valued at US$ 1.18 billion in 2026 and is expected to reach US$ 3.65 billion by 2033.The increased use of personalised medicines is propelling market growth. Small molecule drug conjugates (SMDCs), a promising strategy for targeted therapy, allow...